Blog
RSS FeedPosted by Michael Wonder on 17 Jul 2019
Knight Therapeutics announces Health Canada has approved Nerlynx for early-stage breast cancer
16 July 2019 - Knight Therapeutics announced today that Health Canada has approved Nerlynx (neratinib) for the extended adjuvant treatment of ...
Posted by Michael Wonder on 16 Jul 2019
National regulator denied offer to give Canadian physicians training on abortion pill
16 July 2019 - The group representing Canada’s family doctors turned down an offer from a national abortion group to ...
Posted by Michael Wonder on 13 Jul 2019
Esperoct is now approved in Canada for the treatment of haemophilia A in both children and adults
12 July 2019 - New treatment can help Canadians living with haemophilia A better manage their bleeding episodes ...
Posted by Michael Wonder on 11 Jul 2019
Health Canada has authorised Vyvanse (lisdexamphetamine dimesylate), the first and only, chewable tablet for the treatment of attention deficit/hyperactivity disorder
10 July 2019 - Vyvanse offers an additional option for patients who prefer the convenience of a chewable tablet, or who ...
Posted by Michael Wonder on 11 Jul 2019
Health Canada approves Pomalyst-based triplet combination for patients with multiple myeloma
10 July 2019 - Pomalyst in combination with bortezomib and dexamethasone, provides a new medication option for patients living with multiple ...
Posted by Michael Wonder on 10 Jul 2019
Canada’s labour leaders encourage premiers to embrace universal pharmacare
10 July 2019 - The presidents of federations of labour from across the country are in Saskatoon during the Council ...
Posted by Michael Wonder on 10 Jul 2019
New committee brings diverse patient, family, and caregiver voices to CADTH
10 July 2019 - Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new ...
Posted by Michael Wonder on 07 Jul 2019
Life-changing drug Spinraza still not covered for many Canadians with spinal muscular atrophy
4 July 2019 - For several hundred Canadians with spinal muscular atrophy, Spinraza is a drug that means the difference ...
Posted by Michael Wonder on 01 Jul 2019
American caravan arrives in Canadian 'birthplace of insulin' for cheaper medicine
30 June 2019 - A self-declared “caravan” of Americans bused across the Canada-U.S. border on Saturday, seeking affordable prices for insulin ...
Posted by Michael Wonder on 27 Jun 2019
Canada’s ‘Pharmacare’ idea will face the same obstacles as Obamacare
27 June 2019 - Canadians have long viewed their single payer health care system with a near-religious reverence, largely because ...
Posted by Michael Wonder on 26 Jun 2019
Pharmacare in Canada remains an idealistic pitch, without a realistic plan
26 June 2019 - We still haven't figured out how to make health care truly universal. ...
Posted by Michael Wonder on 24 Jun 2019
Forcing patients to switch to biosimilars puts them in uncharted waters
23 June 2019 - On May 27, the B.C. government announced a policy that will forcibly switch thousands of patients, ...
Posted by Michael Wonder on 19 Jun 2019
Health Canada approves Hemlibra for haemophilia A patients without factor VIII inhibitors
18 June 2019 - Hemlibra is the only treatment that can be self-injected subcutaneously once weekly for patients with hemophilia A ...
Posted by Michael Wonder on 18 Jun 2019
Advisory Council supports biosimilars in call for universal public drug coverage in Canada
17 June 2019 - A Canadian advisory council is recommending the use of biosimilars in a final report that lays ...
Posted by Michael Wonder on 18 Jun 2019
Desperate for lifesaving insulin, Americans head to Canada
18 June 2019 - There’s a new kind of drug runner in town – American mothers of children with Type ...